Adherent Bacteria and Parasiticidal Secretion Products of Human Cervicovaginal Microbiota-Associated Lactobacillus gasseri Confer Non-Identical Cell Protection against Trichomonas vaginalis-Induced Cell Detachment
- PMID: 36355522
- PMCID: PMC9696988
- DOI: 10.3390/ph15111350
Adherent Bacteria and Parasiticidal Secretion Products of Human Cervicovaginal Microbiota-Associated Lactobacillus gasseri Confer Non-Identical Cell Protection against Trichomonas vaginalis-Induced Cell Detachment
Abstract
Trichomonas vaginalis, a protozoan parasite specific to the human genital tract, is one of the most common sexually transmitted pathogens. Its pathogenicity is strongly associated with its expression of a broad array of proteases triggering cytotoxic effects in host epithelial cells. Vaginal microbiota-associated Lactobacillus, including those of L. gasseri in particular, can counteract T. vaginalis pathogenesis, but the mechanisms involved have yet to be clarified. T. vaginalis strain G3 (Tv G3) cytotoxicity was assessed by examining cell morphology, cell detachment, and fluorescent labeling of the F-actin cytoskeleton and immunolabeling of vinculin-position focal adhesions (FAs) by confocal laser scanning electron microscopy on confluent cervicovaginal epithelial HeLa cell monolayers. The inhibitory effects of bacterial cells and secreted products of L. gasseri ATCC 9857 and KS 120.1 on the Tv G3 viability and parasite deleterious effects on HeLa cells were investigated. Pre-adhering L. gasseri cells delayed but did not inhibit Tv G3-induced cell detachment, F-actin cytoskeleton disorganization and the disappearance of vinculin-positive focal FAs. L. gasseri KS 120.1 secretion products had a rapid parasiticide activity by killing time- and concentration-dependent Tv G3 parasites after direct contact. By killing Tv G3 parasites already associated with the epithelial cells, secretion products have abolished parasite-induced cell detachment. Our findings suggest that vagina microbiota-associated L. gasseri creates a physical barrier and exerts pharmacological-type mechanisms to counteract the deleterious cytotoxic effects of T. vaginalis.
Keywords: HeLa cells; Lactobacillus gasseri; Trichomonas vaginalis; adhesion; cytotoxicity; motility; parasiticidal activity; released products; vaginal microbiota.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures






Similar articles
-
Diverse Expression of Antimicrobial Activities Against Bacterial Vaginosis and Urinary Tract Infection Pathogens by Cervicovaginal Microbiota Strains of Lactobacillus gasseri and Lactobacillus crispatus.Front Microbiol. 2019 Dec 20;10:2900. doi: 10.3389/fmicb.2019.02900. eCollection 2019. Front Microbiol. 2019. PMID: 31921075 Free PMC article.
-
A Cell Surface Aggregation-Promoting Factor from Lactobacillus gasseri Contributes to Inhibition of Trichomonas vaginalis Adhesion to Human Vaginal Ectocervical Cells.Infect Immun. 2018 Jul 23;86(8):e00907-17. doi: 10.1128/IAI.00907-17. Print 2018 Aug. Infect Immun. 2018. PMID: 29784856 Free PMC article.
-
Lactobacillus gasseri and Gardnerella vaginalis produce extracellular vesicles that contribute to the function of the vaginal microbiome and modulate host-Trichomonas vaginalis interactions.Mol Microbiol. 2024 Sep;122(3):357-371. doi: 10.1111/mmi.15130. Epub 2023 Jul 24. Mol Microbiol. 2024. PMID: 37485746
-
Trichomonas vaginalis: Pathogenesis, Symbiont Interactions, and Host Cell Immune Responses.Trends Parasitol. 2018 Aug;34(8):683-693. doi: 10.1016/j.pt.2018.05.006. Epub 2018 Jun 29. Trends Parasitol. 2018. PMID: 30056833 Free PMC article. Review.
-
Trichomonas vaginalis origins, molecular pathobiology and clinical considerations.Curr Opin Infect Dis. 2015 Feb;28(1):72-9. doi: 10.1097/QCO.0000000000000128. Curr Opin Infect Dis. 2015. PMID: 25485651 Review.
Cited by
-
The Female Reproductive Tract Microbiota: Friends and Foe.Life (Basel). 2023 Jun 1;13(6):1313. doi: 10.3390/life13061313. Life (Basel). 2023. PMID: 37374096 Free PMC article. Review.
References
-
- Balkus J.E., Richardson B.A., Rabe L.K., Taha T.E., Mgodi N., Kasaro M.P., Ramjee G., Hoffman I.F., Abdool Karim S.S. Bacterial vaginosis and the risk of Trichomonas vaginalis acquisition among hiv-1-negative women. Sex. Transm. Dis. 2014;41:123–128. doi: 10.1097/OLQ.0000000000000075. - DOI - PMC - PubMed
-
- Brotman R.M., Bradford L.L., Conrad M., Gajer P., Ault K., Peralta L., Forney L.J., Carlton J.M., Abdo Z., Ravel J. Association between Trichomonas vaginalis and vaginal bacterial community composition among reproductive-age women. Sex. Transm. Dis. 2012;39:807–812. doi: 10.1097/OLQ.0b013e3182631c79. - DOI - PMC - PubMed
-
- Fichorova R.N., Buck O.R., Yamamoto H.S., Fashemi T., Dawood H.Y., Fashemi B., Hayes G.R., Beach D.H., Takagi Y., Delaney M.L., et al. The villain team-up or how Trichomonas vaginalis and bacterial vaginosis alter innate immunity in concert. Sex. Transm. Infect. 2013;89:460–466. doi: 10.1136/sextrans-2013-051052. - DOI - PMC - PubMed
-
- Swidsinski A., Guschin A., Tang Q., Dorffel Y., Verstraelen H., Tertychnyy A., Khayrullina G., Luo X., Sobel J.D., Jiang X. Vulvovaginal candidiasis: Histologic lesions are primarily polymicrobial and invasive and do not contain biofilms. Am. J. Obstet. Gynecol. 2019;220:91.e1–91.e8. doi: 10.1016/j.ajog.2018.10.023. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous